Clinical Trials on Ovarian Cortical Inclusion Cysts in Korea, Democratic People's Republic of
Total 39 results
-
CHA UniversityUnknownOvarian CystKorea, Republic of
-
Seoul National University HospitalCompletedOvarian Cyst BenignKorea, Republic of
-
Chosun University HospitalCompletedCervical Cancer | Ovarian Cancer | Cholecystitis | Uterine Myoma | Ovarian CystKorea, Republic of
-
Seoul National University HospitalRecruitingBenign Ovarian CystKorea, Republic of
-
Samsung Medical CenterCompletedUterine Myoma | Ovarian Cyst | Laparoscopic Gynecologic SurgeryKorea, Republic of
-
CHA UniversityRecruitingNo ConditionKorea, Republic of
-
CHA UniversityCompleted
-
Seoul National University HospitalCompletedPolycystic Ovary Syndrome | InfertilityKorea, Republic of
-
Kangbuk Samsung HospitalCompletedLaparoscopyKorea, Republic of
-
Chung-Hoon KimCompletedPolycystic Ovary SyndromeKorea, Republic of
-
China Academy of Chinese Medical SciencesDongzhimen Hospital, Beijing; Kyung Hee University Hospital at Gangdong; Korea...UnknownPolycystic Ovary Syndrome | OligomenorrheaKorea, Republic of, China
-
Asan Medical CenterBaxter Healthcare CorporationCompletedCervical Cancer | Gynecologic Cancer | Ovarian Cancer | Endometrial Cancer | Fallopian Tubal CancerKorea, Republic of
-
Royan InstituteCompletedPolycystic Ovary Syndrome | Ovarian Hyperstimulation SyndromeIran, Islamic Republic of
-
Tehran University of Medical SciencesCompletedPolycystic Ovary SyndromeIran, Islamic Republic of
-
Tehran University of Medical SciencesCompletedPCOSIran, Islamic Republic of
-
Royan InstituteCompletedInfertilityIran, Islamic Republic of
-
Shahid Beheshti University of Medical SciencesRecruitingPolycystic Ovary Syndrome | Infertility | ARTIran, Islamic Republic of
-
Royan InstituteCompletedEndocrine System Diseases | Gonadal DisordersIran, Islamic Republic of
-
Royan InstituteCompletedPolycystic Ovary SyndromeIran, Islamic Republic of
-
Shiraz University of Medical SciencesCompletedPolycystic Ovary SyndromeIran, Islamic Republic of
-
Hormozgan University of Medical SciencesCompletedPolycystic Ovary SyndromeIran, Islamic Republic of
-
Tehran University of Medical SciencesCompletedPolycystic Ovary Syndrome | Infertility, FemaleIran, Islamic Republic of
-
Fasa University of Medical SciencesShiraz University of Medical SciencesCompletedPolycystic Ovary SyndromeIran, Islamic Republic of
-
Shahid Beheshti UniversityUnknownPolycystic Ovary SyndromeIran, Islamic Republic of
-
Isfahan University of Medical SciencesUnknownPolycystic Ovary SyndromeIran, Islamic Republic of
-
Seoul National University HospitalUnknownCervical Cancer | Ovarian Cancer | Uterine CancerKorea, Republic of
-
Royan InstituteRecruitingPolycystic Ovary SyndromeIran, Islamic Republic of
-
Royan InstituteCompletedPolycystic Ovary SyndromeIran, Islamic Republic of
-
Asan Medical CenterRecruitingCervical Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Peritoneal CancerKorea, Republic of
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingAdvanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,BreastItaly, Spain, United States, France, Korea, Republic of, Japan, Canada, Denmark, Belgium
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...United States, Australia, Korea, Republic of
-
National Cancer Center, JapanRecruitingCervical Cancer | Nasopharyngeal Carcinoma | Ovarian Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Ovarian Clear Cell CarcinomaJapan, Korea, Republic of, Malaysia, Thailand, Philippines, Singapore, Taiwan, Vietnam
-
NGM Biopharmaceuticals, IncMerck Sharp & Dohme LLCRecruitingMelanoma | Renal Cell Carcinoma | Cervical Cancer | Breast Cancer | Glioblastoma | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Mesothelioma | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Pancreatic Ductal Adenocarcinoma | Endocervical CancerUnited States, Korea, Republic of, Taiwan
-
Medicenna Therapeutics, Inc.Merck Sharp & Dohme LLCRecruitingClear Cell Renal Cell Carcinoma | Cervical Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Solid Tumor | Squamous Cell Carcinoma of Head and Neck | Bladder Cancer | Skin Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Primary Peritoneal Cancer | Endometrial Carcinoma and other conditionsUnited States, Australia, Korea, Republic of, Canada
-
ExelixisRecruitingCervical Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor-positive Breast Cancer | SCCHN | Esophageal SCC | Tissue Factor-Expressing Solid TumorsUnited States, Spain, Australia, Belgium, France, Italy, Netherlands, United Kingdom, Korea, Republic of
-
Advenchen Laboratories, LLCActive, not recruitingFallopian Tube Carcinoma | Cervical Carcinoma | Endometrial Carcinoma | Ovarian Carcinoma | Primary Peritoneal CarcinomaKorea, Republic of, Spain, United States, United Kingdom, China, Italy
-
AstraZenecaRecruitingCervical Cancer | Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Biliary Cancer | Additional Indications Below for Module 4 and 5 | Small Cell Lung Cancer Only in Module 5Canada, Spain, China, Korea, Republic of, Italy, Poland, United States, Australia, United Kingdom, Japan, Hungary, Russian Federation, Czechia
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerCanada, Korea, Republic of, Taiwan, United States, Italy, United Kingdom, Thailand, Russian Federation, India, Belgium, Australia, Poland, Spain, Japan, Brazil, Czechia, Netherlands
-
Merck Sharp & Dohme LLCRecruitingUterine Cervical Neoplasms | Stomach Neoplasms | Urinary Bladder Neoplasms | Hepatocellular Carcinoma | Esophageal Neoplasms | Ovarian Neoplasms | Endometrial Neoplasms | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Triple Negative Breast Neoplasms | Gallbladder NeoplasmsUnited States, Chile, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Spain, Taiwan, Turkey, Canada